Episode

The End of Trial-and-Error Cancer Care

Podcast
AI and Healthcare
Published
Jul 10, 2026
Duration seconds
3380
Processing state
not_requested
Canonical source
https://mtrudnak.podbean.com/e/the-end-of-trial-and-error-cancer-care/
Audio
https://mcdn.podbean.com/mf/web/w236yc37gp5v7ee5/Episode_114_audio7bpv5.mp3
JSON
/v1/public/podcasts/ai-and-healthcare-5049686/episodes/the-end-of-trial-and-error-cancer-care
Markdown
/podcast/ai-and-healthcare-5049686/the-end-of-trial-and-error-cancer-care.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/ai-and-healthcare-5049686/episodes/the-end-of-trial-and-error-cancer-care/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/ai-and-healthcare-5049686/the-end-of-trial-and-error-cancer-care.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Eric Lefkofsky, Founder and CEO of Tempus AI, joins Dr. Sanjay Juneja and Dr. Doug Flora to explore how artificial intelligence, real-world data, genomic sequencing, and emerging technologies like organoids are reshaping oncology. From reducing diagnostic errors to matching patients with more effective therapies, AI is transforming how clinicians make decisions and how researchers develop the next generation of treatments. The conversation examines why healthcare adoption has lagged behind technological progress, the growing role of patient-driven intelligence, and how connected data may help eliminate thousands of preventable cancer deaths each year. Eric also shares his vision for AI-powered clinical decision support, digital twins, drug development, and the future relationship between physicians and intelligent systems.